The main markers of the long-term efficiency of neoadjuvant chemotherapy in breast cancer (review of literature)

The main markers of the long-term efficiency of neoadjuvant chemotherapy in breast cancer (review of literature)

This article deals with the results of a meta-analysis of 12 clinical trials of neoadjuvant therapy in breast cancer. Patients who achievedthe complete morphological regress (marked as урT0урN0 or ут0/isурN0) had improved the survival rate. Predictive value of complete morphological regression for e...

Full description

Bibliographic Details
Main Authors:	V F Semiglazov, V V Semiglazov, P M Paltuev, K S Nikolaev, G A Dashyan
Format:	Article
Language:	Russian
Published:	IP Habib O.N. 2013-12-01
Series:	Современная онкология
Subjects:	breast cancer neoadjuvant chemotherapy
Online Access:	https://modernonco.orscience.ru/1815-1434/article/view/26910

Similar Items

Neoadjuvant treatment for breast cancer
by: V. F. Semiglazov, et al.
Published: (2014-07-01)

Magnetic resonance imaging in evaluation of efficiency of neoadjuvant chemotherapy of breast cancer
by: A. V. Komyahov, et al.
Published: (2015-12-01)

Correlation of the value of sonoelastography strain ratio with the degree of pathological regression in patients with locally advanced breast cancer undergoing neoadjuvant chemotherapy
by: E. A. Bus’ko, et al.
Published: (2017-02-01)

Neoadjuvant chemotherapy for primary sarcoma of the breast: a case report
by: Chieko Miyazaki, et al.
Published: (2019-09-01)

Breast cancer biomarker (ER, PR, HER2) changes in the phenotype after neoadjuvant treatment
by: V. O. Bashlyk, et al.
Published: (2018-07-01)

Evaluation of the Efficacy of Neoadjuvant Chemotherapy for Breast Cancer
by: Wang H, et al.
Published: (2020-06-01)

Prospective Assessment of Systemic MicroRNAs as Markers of Response to Neoadjuvant Chemotherapy in Breast Cancer
by: Andrew McGuire, et al.
Published: (2020-07-01)

Assessment of Predictive Markers of Response to Neoadjuvant Chemotherapy in Breast Cancer
by: Mallika Tewari, et al.
Published: (2010-10-01)

Impact of various options of neoadjuvant chemotherapy on the hormonal status of patients with breast cancer
by: Yu. S. Sidorenko, et al.
Published: (2014-08-01)

Predictors of Neoadjuvant Chemotherapy Response in Breast Cancer: A Review
by: Xu W, et al.
Published: (2020-06-01)

New Advances in the Research of Resistance to Neoadjuvant Chemotherapy in Breast Cancer
by: Junsha An, et al.
Published: (2021-09-01)

NEOADJUVANT ENDOCRINE THERAPY FOR PATIENTS WITH ESTROGEN-RECEPTOR-POSITIVE BREAST CANCER
by: V. F. Semiglazov, et al.
Published: (2018-07-01)

The role of carboplatin in the neoadjuvant chemotherapy treatment of triple negative breast cancer
by: Aurelio Bartolome Castrellon, et al.
Published: (2017-03-01)

Blood cellular markers of inflammation in Breast Cancer and response to Neoadjuvant Chemotherapy
by: Babatunde Ayoade, et al.
Published: (2019-06-01)

COMPARATIVE ANALYSIS OF DIFFERENT NEOADJUVANT CHEMOTHERAPY REGIMENS FOR TRIPLE-NEGATIVE BREAST CANCER
by: P. V. Krivorotko, et al.
Published: (2017-12-01)

RELATIONSHIP OF THE IMMUNOLOGICAL PARAMETRES WITH NEOADJUVANT CHEMOTHERAPY EFFECTIVENESS IN BREAST CANCER PATIENTS
by: Y. V. Kukharev, et al.
Published: (2016-02-01)

How Long is It Safe to Wait for Breast Surgery After Completion of Neoadjuvant Chemotherapy?
by: Ma T, et al.
Published: (2021-02-01)

BRCA1 mRNA expression levels as an predictor of response to neoadjuvant chemotherapy in breast cancer
by: M. M. Tsyganov, et al.
Published: (2018-05-01)

Retrospective audit on time to surgery delays following the completion of neoadjuvant chemotherapy in breast cancer patients
by: Abson, C., et al.
Published: (2022)

Significance of intrinsic breast cancer subtypes on the long-term prognosis after neoadjuvant chemotherapy
by: Wataru Goto, et al.
Published: (2018-11-01)

Role of scintimammography in assessing the response of neoadjuvant chemotherapy in locally advanced breast cancer
by: Romeeta Trehan, et al.
Published: (2014-01-01)

Identification of the plasma total cfDNA level before and after chemotherapy as an indicator of the neoadjuvant chemotherapy response in locally advanced breast cancer
by: Ge Ma, et al.
Published: (2020-04-01)

Predicting Response to Neoadjuvant Chemotherapy in Women with Locally Advanced Breast Cancer in Kenya: Utility of Ki67
by: Edwin Mogere, et al.
Published: (2021-01-01)

Predictive molecular markers of resistance to chemotherapy in breast cancer
by: Valerian Cucieru
Published: (2021-03-01)

Comparison of the efficacy and survival analysis of neoadjuvant chemotherapy for Her-2-positive breast cancer
by: Li S, et al.
Published: (2018-09-01)

EARLY PREDICTION OF RESPONSE TO NEOADJUVANT CHEMOTHERAPY FOR LOCALLY ADVANCED BREAST CANCER USING MRI
by: NAGANAWA, SHINJI, et al.
Published: (2011)

Evaluation of the Effects of Letrozole in Combination with Neoadjuvant Chemotherapy on Clinical Response Rate of Breast Cancer
by: Zahra Mozahheb, et al.
Published: (2021-03-01)

Treatment times in breast cancer patients receiving neoadjuvant vs adjuvant chemotherapy: Is efficiency a benefit of preoperative chemotherapy?
by: Nicole M. Melchior, et al.
Published: (2020-04-01)

Amplifications of Stemness Gene Loci—New Markers for the Determination of the Need for Neoadjuvant Chemotherapy for Patients with Breast Cancer. A Prospective Study
by: Nikolai V. Litviakov, et al.
Published: (2021-05-01)

A combination of paclitaxel and gemcitabine in an intensive dose-dense neoadjuvant chemotherapy schedule for locally advanced breast cancer
by: I. V. Frai, et al.
Published: (2014-08-01)

BRCAness as an Important Prognostic Marker in Patients with Triple-Negative Breast Cancer Treated with Neoadjuvant Chemotherapy: A Multicenter Retrospective Study
by: Yoshimasa Kosaka, et al.
Published: (2020-02-01)

Oncological outcome of complete response after neoadjuvant chemotherapy for breast conserving surgery: a systematic review and meta-analysis
by: Xuan Li, et al.
Published: (2017-11-01)

Evaluation of Clinical and Pathological Response to Neoadjuvant Chemotherapy in Patients with Locally Advanced Breast Cancer and Correlation with Biological Factors and Type of Chemotherapy
by: Seyed Hadi Chavoshi, et al.
Published: (2018-09-01)

Neoadjuvant Chemotherapy and Surgical Options for Locally-advanced Breast Cancer: A Single Institution Experience
by: Mohamed Abo Elmagd Salem, et al.
Published: (2017-07-01)

Predicting the response to neoadjuvant chemotherapy for breast cancer: wavelet transforming radiomics in MRI
by: Jiali Zhou, et al.
Published: (2020-02-01)

Mechanisms behind prometastatic changes induced by neoadjuvant chemotherapy in the breast cancer microenvironment
by: Perelmuter VM, et al.
Published: (2019-07-01)

Clinical efficacy of neoadjuvant FAC chemotherapy in locally advanced breast cancer patients
by: Ždrale Zdravko, et al.
Published: (2003-01-01)

Neoadjuvant hormonal therapy is associated with comparable outcomes to neoadjuvant chemotherapy in post-menopausal women with estrogen receptor-positive breast cancer
by: David M. Marcus, et al.
Published: (2013-12-01)

Sentinel lymph node biopsy and neoadjuvant chemotherapy in the management of early breast cancer: Safety considerations and timing
by: Jenny Edge, et al.
Published: (2017-06-01)

Neoadjuvant Chemotherapy in Breast Cancer: Review of the Evidence and Conditions That Facilitated Its Use during the Global Pandemic
by: Tabitha Tse, et al.
Published: (2021-03-01)